WEBMD HEALTH CORP's gross profit margin for the second quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. The company has grown its sales and net income during the past quarter when compared with the same quarter a year ago, and although its growth in net income has outpaced the industry average, its revenue growth has not. WEBMD HEALTH CORP is extremely liquid. Currently, the Quick Ratio is 2.13 which clearly shows the ability to cover any short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 40.99% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is very unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q2 FY15||Q2 FY14|
|Net Sales ($mil)||148.32||140.4|
|Net Income ($mil)||13.37||9.72|
|Balance Sheet||Q2 FY15||Q2 FY14|
|Cash & Equiv. ($mil)||757.38||781.31|
|Total Assets ($mil)||1234.5||1279.45|
|Total Debt ($mil)||952.23||952.23|
|Profitability||Q2 FY15||Q2 FY14|
|Gross Profit Margin||59.27||61.21|
|Return on Assets||4.0||2.34|
|Return on Equity||55.17||20.22|
|Debt||Q2 FY15||Q2 FY14|
|Share Data||Q2 FY15||Q2 FY14|
|Shares outstanding (mil)||36.84||38.11|
|Div / share||0.0||0.0|
|Book value / share||2.38||3.9|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||296148.0||351995.0|
HOLD. WEBMD HEALTH CORP's P/E ratio indicates a discount compared to an average of 45.30 for the Internet Software & Services industry and a significant premium compared to the S&P 500 average of 20.03. For additional comparison, its price-to-book ratio of 17.39 indicates a significant premium versus the S&P 500 average of 2.67 and a significant premium versus the industry average of 5.05. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. The valuation analysis reveals that, WEBMD HEALTH CORP seems to be trading at a discount to investment alternatives within the industry.
|WBMD 35.65||Peers 45.30||WBMD 13.05||Peers 24.55|
Discount. A lower P/E ratio than its peers can signify a less expensive stock or lower growth expectations.
WBMD is trading at a discount to its peers.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
WBMD is trading at a significant discount to its peers.
|WBMD 28.13||Peers 22.56||WBMD 0.84||Peers 0.67|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
WBMD is trading at a significant premium to its peers.
Premium. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
WBMD trades at a significant premium to its peers.
|WBMD 17.39||Peers 5.05||WBMD 68.11||Peers 91.57|
Premium. A higher price-to-book ratio makes a stock less attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
WBMD is trading at a significant premium to its peers.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, WBMD is expected to significantly trail its peers on the basis of its earnings growth rate.
|WBMD 2.55||Peers 8.57||WBMD 8.42||Peers 70.38|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
WBMD is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
WBMD significantly trails its peers on the basis of sales growth
Select the service that is right for you!COMPARE ALL SERVICES
Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV